Umea University

7 trials 4 recruiting Academic / non-commercial

Filter these 7 trials by condition, phase, country and more.

Open in Search →

7 Registered trials

4 Recruiting

0 Completed trials

3 Countries active

21 Unique IMPs

N/A Results reported

Phase III

Phase II

Phase III/IV

Phase IV

Phase III: 4 Phase II: 1 Phase III/IV: 1 Phase IV: 1

Top indications

Prostate cancer 1

Top IMPs

177LU-PSMA-I&T 1 APALUTAMIDE 1 DENGUE VIRUS, SEROTYPE 2, LIVE, ATTENUATED, DENGUE VIRUS, SEROTYPE 2, EXPRESSING DENGUE VIRUS, SEROTYPE 1, SURFACE PROTEINS, LIVE, ATTENUATED, DENGUE VIRUS, SEROTYPE 2, EXPRESSING DENGUE VIRUS, SEROTYPE 3, SURFACE PROTEINS, LIVE, ATTENUATED, DENGUE VIRUS, SEROTYPE 2, EXPRESSING DENGUE VIRUS, SEROTYPE 4, SURFACE PROTEINS, LIVE, ATTENUATED 1 ENZALUTAMIDE 1 GADOTERIC ACID 1 GLUCAGON 1 HUMAN NORMAL IMMUNOGLOBULIN 1 HYOSCINE BUTYLBROMIDE 1 NIRMATRELVIR 1 PREDNISOLONE 1 REMDESIVIR 1

All trials

7 total

Nordic PREdnisolon for VEstibular NeuriTis Study – an investigator-driven, triple blind, placebo controlled randomized trial Pending

2025-522399-10-00 Phase III 3 countries PREDNISOLONE
Postoperative recovery with the addition of long-acting NK1- and 5-HT3 receptor antagonists as prophylaxis for post-operative nausea and vom… Pending

2025-522529-36-00 Phase III 1 country
Randomized Open Label Trial Evaluating Efficacy and Safety of Intravenous Immunoglobulin (IVIg, Privigen) as Add-on to SoC Versus SoC Alone … Pending

2025-522756-97-00 Phase II 1 country HUMAN NORMAL IMMUNOGLOBULIN; NIRMATRELVIR; REMDESIVIR
An open non-randomized phase IV trial examining interfering cross-reactivity in serological diagnostics of flavivirus infections in Swedish … Recruiting

2025-520655-92-00 Phase IV 1 country DENGUE VIRUS, SEROTYPE 2, LIVE, ATTENUATED, DENGUE VIRUS, SEROTYPE 2, EXPRESSING…
LOWOX Recruiting

2024-513117-12-00 Phase III/IV 1 country
Evaluation of PSMA-PET and mpMRI in high-risk prostate cancer – using histopathologic validation Recruiting

2022-501892-14-00 Phase III 1 country GADOTERIC ACID; GLUCAGON; HYOSCINE BUTYLBROMIDE
A Randomised study comparing Lutetium-177 versus Apalutamide/Enzalutamide/Abiraterone, in metastatic Hormon Sensitive Prostate Cancer in PSM… Recruiting

2022-500570-33-00 Phase III 1 country 177LU-PSMA-I&T; APALUTAMIDE; ENZALUTAMIDE

Showing 1–7 of 7 trials

← All sponsors A–Z